Pathstone Holdings »

Sab Biotherapeutics shares owned by Pathstone Holdings

Quarter-by-quarter ownership of Sab Biotherapeutics (SABS) shares owned by Pathstone Holdings from 13F filings

Historical chart of Pathstone Holdings investment in Sab Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sab Biotherapeutics held by Pathstone Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sab Biotherapeutics by Pathstone Holdings

Quarter filed Position value Share count Share price at filing
2024-06-30 $157k 51k 3.10
2024-03-31 $230k 51k 4.54

More positions owned by Pathstone Holdings

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Core S&p500 Etf (IVV)
Microsoft Corporation (MSFT)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Berkshire Hathaway Inc Del Cl A (BRK.A)
Apple (AAPL)
Spdr S&p Midcap 400 Etf Tr Utser1 S&pdcrp (MDY)
Ishares Tr Core S&p Mcp Etf (IJH)
NVIDIA Corporation (NVDA)
Ishares Tr Rus 1000 Etf (IWB)
Ishares Tr Core S&p Scp Etf (IJR)
Amazon (AMZN)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Crowdstrike Hldgs Cl A (CRWD)
Vanguard Index Fds Large Cap Etf (VV)

View all positions for Pathstone Holdings

Top funds holding Sab Biotherapeutics

BVF
Marshall Wace
Sessa Capital IM
Vanguard Group
HB Wealth Management
Geode Capital Management
Millennium Management
Pathstone Holdings
First Manhattan
First PREMIER Bank
Institutional & Family Asset Management
BlackRock
Tower Research Capital
Morgan Stanley
Princeton Global Asset Management

View all funds holding Sab Biotherapeutics